medigraphic.com
Colegio de Medicina Interna de México.

2020, Number 1

<< Back Next >>

Med Int Mex 2020; 36 (1)

Severe hypernatremia and rhabdomyolysis due to malignant neuroleptic syndrome

García-Habeych JM, Agudelo MR, Báez-Duarte JP, Mendinueta-Giacomatto SA, Solano-González RA

Language: Spanish
References: 15
Page: 107-112
PDF size: 192.88 Kb.


ABSTRACT

Background: Hypernatremia and rhabdomyolysis are clinical entities that are associated separately with mortality and hospital complications. Its combined presentation is infrequent and multiple etiologies have been described.
Clinical case: An 18-year-old male patient who had severe hypernatremia associated with rhabdomyolysis secondary to haloperidol complicated by a neuroleptic malignant syndrome.
Conclusions: Rhabdomyolysis-hypernatremia is an infrequent clinical illness requiring the individual approach of each case for its corresponding treatment.


REFERENCES

  1. Ramin S, Iraj F. Understanding hypernatremia. Am J Nephrol 2012;36:97-104. doi: 10.1159/000339625.

  2. Akirov A, Diker-Cohen T, Steinmetz Tali, Amitai O, Shimon I. Sodium levels on admission are associated with mortality risk in hospitalized patients. Eur J Intern Med 2017;46:25-9. doi: 10.1016/j.ejim.2017.07.017.

  3. Cervellin G, Comelli L, Benatti M. Non-traumatic rhabdomyolysis: Background, laboratory features, and acute clinical management. Clin Biochem 2017;50(12):656-62. doi: 10.1016/j.clinbiochem.2017.02.016.

  4. Muhsin S, Mount D. Diagnosis and treatment of hypernatremia. Best Pract Res Clin Endocrinol Metab 2016;30:189- 203. doi: 10.1016/j.beem.2016.02.014.

  5. Biharis S, Prakash S, Potts S, Metheson E, Bersten A. Addressing the inadvertent sodium and chloride burden in critically ill patients: a prospective before-and-after study in a tertiary mixed intensive care unit population (Abstract). Crit Care Resusc 2018;20(4):285-93.

  6. Ficha técnica Piperacilina/Tazobactam ACCORDPHARMA 2/0,25g polvo y disolvente para solucion inyectable. [In ternet]. https://cima.aemps.es/cima/dochtml/ft/68206/ FT_68206.html. 2019 [citado 3 de enero de 2019]. Disponible en: https://cima.aemps.es/cima/dochtml/ft/68206/ FT_68206.html.

  7. Petejova N, Martinek A. Acute kidney injury due to rhabdomyolysis and renal replacement therapy: a critical review. Crit Care 2014;18(3):224. doi: 10.1186/cc13897.

  8. Melli G, Chaudhry V, Cornblath D. Rhabdomyolysis. An evaluation of 475 hospitalized patientes. Medicine (Baltimore) 2005;84:377-85. DOI: 10.1097/01. md.0000188565.48918.41.

  9. Sabzghabaei F, Rastegar A. Adipsic hypernatremic myopathy. Iran J Kidney Dis 2015;9:256-8.

  10. Yang T-Y, Chang J-W, Tseng M-H. Extreme hypernatremia combined with rhabdomyolysis and acute renal failure. J Chin Med Assoc 2009;72(10):55-558. doi: 10.1016/S1726- 4901(09)70428-9.

  11. Ramthun M, Mocelin A, Alvares V. Hypernatremia secundary to post-stroke hypodipsia: Just add water! Nephrol Dial Transplant 2011;4:236-7. doi: 10.1093/ndtplus/sfr057.

  12. Holley A, Green S, Daroven P. Extreme hypernatremia: a case report and brief review. Crit Care Resucitation 2007;9:55-8.

  13. Strachan S, Morris L. Management of severe dehydration. J Intensive Care Soc 2017;18(3):251-5. doi: 10.1177/1751143717693859.

  14. Lindner G, Schwarz C, Kneidinger N, Kramer L. Can we really predict the change in serum sodium levels? An analysis of currently proposed formulae in hypernatraemic patients. Nephrol Dial Transplant 2008;23:3501-8. doi: 10.1093/ndt/gfn476.

  15. Hoste E, Colpaert K, Vanholder R. Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis. J Nephrol 18:303-7.




2020     |     www.medigraphic.com